Cerapedics
PrivateLast Round
VC Round
Mar 7, 2022
Total Funding Raised
$114.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cerapedics operates in Healthcare & Life Sciences and is based in Westminster, Colorado. Its latest recorded funding round was a VC Round in March 2022.
Cerapedics is an orthobiologics company that develops and commercializes proprietary synthetic small peptide (P-15) technology platforms for bone repair and orthopedic procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerapedics Comparables
Compare Cerapedics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kuros Biosciences AG | 83% | |
| Isto Biologics | 80% | |
| Zavation Medical Products | 79% |
For institutional investors. Book with your work email.
Cerapedics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 7, 2022 | ||||
| VC Round | Jul 13, 2018 | ||||
| Debt | Apr 19, 2017 | ||||
| Series D | Sep 23, 2016 | ||||
| Debt | Apr 7, 2015 | ||||
Early Funding | Mar 25, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cerapedics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | VC Round |
| Perceptive Advisors | VC Round |
| GE Capital | Debt, Venture Debt |
| OrbiMed | Series B, Series C, Series A |
| MedImmune Ventures | Series C |
| Oxford Finance | Debt |
| NGN Capital | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Next-generation product evaluated in pivotal ASPIRE FDA IDE study.
- Jan 1, 2026
Next-generation product granted Breakthrough Device Designation by the FDA.
For institutional investors. Book with your work email.
Cerapedics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cerapedics's valuation, stock price, and market status.
Is Cerapedics a public or private company?
Cerapedics is a private company.
What is the current stock price of Cerapedics?
Cerapedics is a private company, so its shares have no public market price. Caplight tracks Cerapedics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cerapedics worth (valuation)?
Valuation information for Cerapedics is not publicly available.
Can I buy Cerapedics stock?
Cerapedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cerapedics's last funding round?
Cerapedics's most recent funding round was VC Round on March 7, 2022.
Who are the main investors in Cerapedics?
Key investors in Cerapedics include KCK MedTech, GE Capital, OrbiMed, MedImmune Ventures, Oxford Finance.
Will Cerapedics IPO soon?
No public IPO plans have been announced for Cerapedics.
How can I track Cerapedics secondary market activity?
Caplight tracks bids, offers, and trades in Cerapedics's shares on secondary markets.